37 articles
Ramón Bataller
Ramón Bataller is a Spanish hepatologist known for work on liver fibrosis and alcohol-associated liver disease, leading the Steatohepatitis and liver transplantation group at Hospital Clínic de Barcelona.
Rebecca Taub
Rebecca Taub is a physician-scientist in hepatology and molecular biology who founded Madrigal Pharmaceuticals and led development of resmetirom, the first FDA-approved MASH drug, approved in 2024.
Rohit Loomba
Rohit Loomba is an American hepatologist at UC San Diego who runs clinical trials of treatments for fatty liver disease and helped establish MRI-based measures of liver fat.
Stanley J. Wolfe
Stanley J. Wolfe (1923–2018) was an American physician and liver researcher at Harvard Medical School and Boston City Hospital, later a gastroenterologist and clinical professor at UCSF.
Stephen A. Harrison
Stephen A. Harrison (1969–2024) was an American hepatologist who retired from the Army as a Colonel, led the trials behind the first FDA-approved MASH drug, and died at 55.
Vlad Ratziu
Vlad Ratziu is a French hepatologist and professor at Pitié-Salpêtrière Hospital in Paris, known for research on fatty liver disease and as co-lead investigator of the MAESTRO-NASH resmetirom trial.
Zobair M. Younossi
Zobair M. Younossi is an American hepatologist and outcomes researcher known for research on fatty liver disease, who joined Georgetown University School of Medicine in 2025.